Court Square Capital Partners, a leading middle-market private equity firm, and WindRose Health Investors (“WindRose”), the New York-based healthcare private equity firm, announced the closing of a jointly controlled investment in Soleo Health (“Soleo” or the “Company”), a national provider of specialty pharmacy and infusion services.
Headquartered in Frisco, Texas, Soleo provides high-touch specialty pharmacy and infusion services to over 22,000 patients annually through a nationwide network of specialty home infusion pharmacies and ambulatory infusion suites. Through its omnichannel approach and access to life-saving therapies across a wide range of therapeutic areas, Soleo delivers differentiated care to enhance the lives of patients with complex, chronic, and acute conditions.
Health Technology Insights: Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making
“We are thrilled to partner with WindRose and Court Square on the next phase of our growth strategy. They share our commitment to excellence, and their expertise and guidance will continue to enhance our reputation as a premier healthcare service provider, helping shape the landscape of the industry with our exceptionally talented team of professionals. Together, we are dedicated to improving the lives of our patients,” said Drew Walk, Co-Founder, President and CEO of Soleo Health.
Court Square and WindRose partnered with Drew, Craig Vollmer, Co-Founder and Chief Commercial Officer, and the rest of the executive team to recapitalize the business and provide additional capital to support future growth. The strategic investment will enable Soleo to continue to scale and expand its footprint to care for more patients and serve additional clients across all 50 states.
Health Technology Insights: Telix Completes Acquisition of Next-Generation Therapeutic Assets
“We are excited to be partnering with Drew, Craig, and the Soleo team. We believe Soleo offers a market-leading and differentiated service to patients across the country. Together with Court Square, we look forward to accelerating Soleo’s expansion while maintaining the high level of care that is core to the Company’s mission,” stated CJ Burnes, Partner at WindRose.
“Soleo’s founder-led identity and commitment to providing comprehensive, personalized, and patient-centric care aligns perfectly with our investment strategy. We have been impressed by Drew, Craig, and the entire Soleo team, and we look forward to working with them and WindRose to support the Company’s continued growth,” said David Nguyen, Managing Partner at Court Square.
Health Technology Insights: Stretched to the Limit: Hospital Union to Line-Up Gurneys Outside Queensway Carleton
Houlihan Lokey acted as exclusive financial advisor to Soleo. Polsinelli PC served as legal advisor to Soleo and its management team. Latham & Watkins LLP and Dechert LLP served as legal advisors to WindRose and Court Square. Cantor Fitzgerald served as financial advisor to Court Square and WindRose.
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
